Roei David Mazor

1.4k total citations
23 papers, 551 citations indexed

About

Roei David Mazor is a scholar working on Physiology, Immunology and Molecular Biology. According to data from OpenAlex, Roei David Mazor has authored 23 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Roei David Mazor's work include Histiocytic Disorders and Treatments (11 papers), Extracellular vesicles in disease (4 papers) and Mast cells and histamine (4 papers). Roei David Mazor is often cited by papers focused on Histiocytic Disorders and Treatments (11 papers), Extracellular vesicles in disease (4 papers) and Mast cells and histamine (4 papers). Roei David Mazor collaborates with scholars based in Israel, United States and France. Roei David Mazor's co-authors include Yehuda Shoenfeld, Alessandra Soriano, Nancy Agmon‐Levin, Serena Colafrancesco, Carlo Perricone, Ziv Shulman, Liat Stoler‐Barak, Irina Zaretsky, Alexander D. Gitlin and Britta Engelhardt and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Kidney International.

In The Last Decade

Roei David Mazor

18 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roei David Mazor Israel	10	234	163	157	145	73	23	551
Ana‐Luisa Stefanski Germany	12	163 0.7×	137 0.8×	240 1.5×	137 0.9×	68 0.9×	34	583
Chenxiong Le United States	8	116 0.5×	87 0.5×	175 1.1×	66 0.5×	78 1.1×	11	512
Michiel Heron Netherlands	13	212 0.9×	54 0.3×	153 1.0×	81 0.6×	119 1.6×	31	666
P.J. Weiller France	14	94 0.4×	155 1.0×	72 0.5×	174 1.2×	63 0.9×	60	638
Frans G. M. Kroese Netherlands	14	265 1.1×	101 0.6×	284 1.8×	42 0.3×	86 1.2×	38	722
Tobias Scheel Germany	10	139 0.6×	149 0.9×	502 3.2×	48 0.3×	106 1.5×	13	786
Víctor Llorenç Spain	21	135 0.6×	336 2.1×	100 0.6×	45 0.3×	128 1.8×	76	1.4k
Angela Wawer Germany	15	102 0.4×	52 0.3×	163 1.0×	144 1.0×	108 1.5×	25	710
L. Têtu France	12	116 0.5×	50 0.3×	248 1.6×	169 1.2×	31 0.4×	33	770
Ali Yalçindağ United States	13	357 1.5×	202 1.2×	380 2.4×	42 0.3×	75 1.0×	20	936

Countries citing papers authored by Roei David Mazor

Since Specialization

Citations

This map shows the geographic impact of Roei David Mazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roei David Mazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roei David Mazor more than expected).

Fields of papers citing papers by Roei David Mazor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roei David Mazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roei David Mazor. The network helps show where Roei David Mazor may publish in the future.

Co-authorship network of co-authors of Roei David Mazor

This figure shows the co-authorship network connecting the top 25 collaborators of Roei David Mazor. A scholar is included among the top collaborators of Roei David Mazor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roei David Mazor. Roei David Mazor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horwitz, Mitchell E., Gary J. Schiller, Sang‐Bing Tsai, et al.. (2025). Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program. Transplantation and Cellular Therapy. 31(7). 436–447.

Salmon‐Divon, Mali, Ofer Shpilberg, Elimelech Okon, et al.. (2024). The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms. Leukemia. 39(2). 516–519. 2 indexed citations

Shaffer, Brian C., Matthew J. Frigault, Muhamad Alhaj Moustafa, et al.. (2024). A Phase I/II Study of GDA-201, Cryopreserved Nicotinamide-Enhanced Allogeneic Natural Killer Cells, in Patients with Relapsed/Refractory B-Cell Lymphoma. Transplantation and Cellular Therapy. 30(2). S196–S196.

Szabolcs, Paul, Roei David Mazor, Dima Yackoubov, et al.. (2023). Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy. Transplantation and Cellular Therapy. 29(8). 517.e1–517.e12. 6 indexed citations

Durham, Benjamin H., Oshrat Hershkovitz‐Rokah, Omar Abdel‐Wahab, et al.. (2023). Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms. Blood Advances. 7(23). 7319–7328. 7 indexed citations

Zorea, Jonathan, Yair Motro, Roei David Mazor, et al.. (2023). TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 107–107. 5 indexed citations

Horwitz, Mitchell E., Sang‐Bing Tsai, Andrew R. Rezvani, et al.. (2023). Omidubicel-Onlv for Allogeneic Transplantation (allo-HCT) in Patients with Hematologic Malignancies: Results of a Multicenter Open Label Expanded Access Program. Blood. 142(Supplement 1). 6894–6894.

Chazal, Thibaud, Francesco Pegoraro, Alessandra Bettiol, et al.. (2022). Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis. Kidney International. 103(1). 177–186. 12 indexed citations

Mazor, Roei David, et al.. (2022). P1122: EFFICACY OF ALPELISIB IN PI3K-DRIVEN LANGERHANS CELL HISTIOCYTOSIS. HemaSphere. 6. 1012–1013. 1 indexed citations

10.

Klompus, Shelley, Sigal Leviatan, Thomas Vogl, et al.. (2021). Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers. Science Immunology. 6(61). 30 indexed citations

11.

Diamond, Eli L., Julien Haroche, Benjamin H. Durham, et al.. (2021). MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis. Leukemia. 36(4). 1139–1149. 17 indexed citations

12.

Diamond, Eli L., Julien Haroche, Nir Pillar, et al.. (2020). The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim–Chester Disease. Cancers. 12(11). 3240–3240. 9 indexed citations

13.

Weissmann‐Brenner, Alina, Chen Hoffmann, Roei David Mazor, et al.. (2018). Added Value of Fetal MRI in the Evaluation of Fetal Anomalies of the Corpus Callosum: A Retrospective Analysis of 78 Cases. Ultraschall in der Medizin - European Journal of Ultrasound. 39(5). 513–525.

14.

Zaretsky, Irina, Roei David Mazor, Liat Stoler‐Barak, et al.. (2017). ICAMs support B cell interactions with T follicular helper cells and promote clonal selection. The Journal of Experimental Medicine. 214(11). 3435–3448. 72 indexed citations

15.

Mazor, Roei David, et al.. (2016). The inter-observer variability of breast density scoring between mammography technologists and breast radiologists and its effect on the rate of adjuvant ultrasound. European Journal of Radiology. 85(5). 957–962. 4 indexed citations

16.

Weissmann‐Brenner, Alina, Omer Bar‐Yosef, Chen Hoffman, et al.. (2016). OP07.08: Added value of fetal MRI in the evaluation of fetal anomalies of the corpus callosum: a retrospective analysis of 78 cases. Ultrasound in Obstetrics and Gynecology. 48(S1). 73–73.

17.

Mazor, Roei David, Anat Kesler, Orna Aizenstein, et al.. (2014). Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series. BMC Medicine. 12(1). 221–221. 23 indexed citations

18.

Mazor, Roei David, et al.. (2013). Erdheim-Chester Disease: a comprehensive review of the literature. Orphanet Journal of Rare Diseases. 8(1). 137–137. 159 indexed citations

19.

Perricone, Carlo, Serena Colafrancesco, Roei David Mazor, et al.. (2013). Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. Journal of Autoimmunity. 47. 1–16. 170 indexed citations

20.

Mazor, Roei David, et al.. (2013). Strategies and treatment alternatives in the management of Erdheim–Chester disease. Expert Opinion on Orphan Drugs. 1(11). 891–899. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact